Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
- PMID: 15809662
- DOI: 10.1038/sj.ijo.0802954
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Abstract
Background: The brain endogenous cannabinoid system modulates reward and craving pathways and consequently may affect body weight. A naturally occurring missense polymorphism in the gene encoding fatty acid amide hydrolase (FAAH), the primary enzyme for inactivation of endocannabinoids, is associated with problem drug use.
Aims: To investigate the relationship between the FAAH cDNA 385 A/A (P129T) polymorphism and overweight disorders in subjects of multiple ethnic backgrounds attending a medical screening clinic.
Subjects: A total of 2667 subjects of white, black and Asian ancestry were genotyped and stratified by a standardized clinic-based assessment of body mass index (BMI, weight in kilograms/(height in meters)(2) or kg/m(2)).
Methods: Subjects were genotyped for the FAAH cDNA 385 C --> A polymorphism using allele-specific oligonucleotide hybridization methods by investigators blinded to all clinical information. BMI was calculated based on exact clinical measurements and World Health Organization ranges were used to stratify subjects. Statistical methods included the Fisher exact test, Mann-Whitney U-test and multivariable logistic regression analysis.
Results: The homozygous FAAH 385 A/A genotype was significantly associated with overweight and obesity in white subjects (P=0.005) and in black subjects (P=0.05) but not in a small group of Asians. The median BMI for all subjects was significantly greater in the FAAH 385 A/A genotype group compared to heterozygote and wild-type groups (P=0.0001). In white subjects, there was an increasing frequency of the FAAH 385 A/A genotype with increasing BMI categories of overweight (P=0.02) and obese (P=0.006) with the same trend in black subjects.
Conclusions: These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.
Similar articles
-
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.Hum Genet. 2006 Nov;120(4):581-8. doi: 10.1007/s00439-006-0250-x. Epub 2006 Sep 14. Hum Genet. 2006. PMID: 16972078
-
The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.Psychoneuroendocrinology. 2008 May;33(4):546-50. doi: 10.1016/j.psyneuen.2008.01.004. Epub 2008 Mar 4. Psychoneuroendocrinology. 2008. PMID: 18295974
-
Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance.Nutr Hosp. 2010 Nov-Dec;25(6):993-8. Nutr Hosp. 2010. PMID: 21519771
-
Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases.Biofactors. 2023 Jan;49(1):62-78. doi: 10.1002/biof.1911. Epub 2022 Oct 27. Biofactors. 2023. PMID: 36300805 Review.
-
Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective.Cannabis Cannabinoid Res. 2023 Feb;8(1):56-76. doi: 10.1089/can.2021.0237. Epub 2022 Jul 27. Cannabis Cannabinoid Res. 2023. PMID: 35900294 Review.
Cited by
-
Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity.J Diabetes Complications. 2020 Nov;34(11):107682. doi: 10.1016/j.jdiacomp.2020.107682. Epub 2020 Jul 17. J Diabetes Complications. 2020. PMID: 32732136 Free PMC article.
-
Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14966-71. doi: 10.1073/pnas.1212887109. Epub 2012 Aug 21. Proc Natl Acad Sci U S A. 2012. PMID: 22912404 Free PMC article.
-
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.Hum Genet. 2006 Nov;120(4):581-8. doi: 10.1007/s00439-006-0250-x. Epub 2006 Sep 14. Hum Genet. 2006. PMID: 16972078
-
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men.Endocrine. 2007 Apr;31(2):138-41. doi: 10.1007/s12020-007-0022-y. Endocrine. 2007. PMID: 17873324
-
Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa.Child Adolesc Psychiatry Ment Health. 2008 Nov 17;2(1):33. doi: 10.1186/1753-2000-2-33. Child Adolesc Psychiatry Ment Health. 2008. PMID: 19014633 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical